DK0560932T3 - - Google Patents
Info
- Publication number
- DK0560932T3 DK0560932T3 DK92902782.9T DK92902782T DK0560932T3 DK 0560932 T3 DK0560932 T3 DK 0560932T3 DK 92902782 T DK92902782 T DK 92902782T DK 0560932 T3 DK0560932 T3 DK 0560932T3
- Authority
- DK
- Denmark
- Prior art keywords
- gene
- products
- neu
- expression
- pct
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US62146590A | 1990-12-04 | 1990-12-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0560932T3 true DK0560932T3 (ja) | 1997-02-17 |
Family
ID=24490270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92902782.9T DK0560932T3 (ja) | 1990-12-04 | 1991-12-04 |
Country Status (11)
Country | Link |
---|---|
US (1) | US5651964A (ja) |
EP (1) | EP0560932B1 (ja) |
JP (2) | JPH06504671A (ja) |
AT (1) | ATE142261T1 (ja) |
AU (1) | AU651650B2 (ja) |
CA (1) | CA2096723C (ja) |
DE (1) | DE69121903T2 (ja) |
DK (1) | DK0560932T3 (ja) |
ES (1) | ES2093248T3 (ja) |
GR (1) | GR3021805T3 (ja) |
WO (1) | WO1992010573A1 (ja) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5643567A (en) * | 1990-12-04 | 1997-07-01 | Board Of Regents, The University Of Texas System | Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen |
US5641484A (en) * | 1990-12-04 | 1997-06-24 | Board Of Regents, The University Of Texas System | Methods for the suppression of neu mediated tumors by adenoviral E1A and SV40 large T antigen |
US5516631A (en) * | 1992-10-13 | 1996-05-14 | La Jolla Cancer Research Foundation | Method of inhibiting replication of hyperproliferative cells |
AU5962694A (en) * | 1992-12-31 | 1994-08-15 | Exemplar Corporation | Producing cells for transplantation to reduce host rejection and resulting cells |
US5776743A (en) | 1994-09-06 | 1998-07-07 | La Jolla Cancer Research Foundation | Method of sensitizing tumor cells with adenovirus E1A |
US6326356B1 (en) * | 1996-10-18 | 2001-12-04 | Board Of Regents, The University Of Texas System | Suppression of neu overexpression using a mini-E1A gene |
US5795587A (en) | 1995-01-23 | 1998-08-18 | University Of Pittsburgh | Stable lipid-comprising drug delivery complexes and methods for their production |
US6008202A (en) * | 1995-01-23 | 1999-12-28 | University Of Pittsburgh | Stable lipid-comprising drug delivery complexes and methods for their production |
US6267958B1 (en) | 1995-07-27 | 2001-07-31 | Genentech, Inc. | Protein formulation |
US5763415A (en) * | 1995-08-03 | 1998-06-09 | John Hopkins University School Of Medicine | Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer |
US6861506B1 (en) | 1996-01-11 | 2005-03-01 | Corixa Corporation | Compositions and methods for the treatment and diagnosis of breast cancer |
US7241876B2 (en) | 1996-01-11 | 2007-07-10 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
US6828431B1 (en) | 1999-04-09 | 2004-12-07 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of breast cancer |
US6656480B2 (en) | 1996-01-11 | 2003-12-02 | Corixa Corporation | Compositions and methods for the treatment and diagnosis of breast cancer |
EP0894139A1 (en) * | 1996-03-20 | 1999-02-03 | Board Of Regents The University Of Texas System | Sensitization of her-2/neu overexpressing cancer cells to chemotherapy |
US7371376B1 (en) | 1996-10-18 | 2008-05-13 | Genentech, Inc. | Anti-ErbB2 antibodies |
US7049410B2 (en) * | 1999-05-14 | 2006-05-23 | Majumdar Adhip P N | Antibodies to a novel EGF-receptor related protein (ERRP) |
WO2000069909A1 (en) | 1999-05-14 | 2000-11-23 | The United States Of America Through The Department Of Veterans Affairs | Isolation and characterization of epidermal growth factor related protein |
US9486429B2 (en) | 1999-06-01 | 2016-11-08 | Vanderbilt University | Therapeutic methods employing nitric oxide precursors |
US6346382B1 (en) | 1999-06-01 | 2002-02-12 | Vanderbilt University | Human carbamyl phosphate synthetase I polymorphism and diagnostic methods related thereto |
PT1210115E (pt) | 1999-08-27 | 2009-11-12 | Genentech Inc | Dosagens para tratamento com anticorpos anti-erbb2 |
WO2002053701A2 (en) * | 2000-12-29 | 2002-07-11 | Vanderbilt University | Epididymal lipocalin gene and uses thereof |
US20020169126A1 (en) * | 2001-03-21 | 2002-11-14 | Mien-Chie Hung | Compositions and methods for inactivating the Akt oncogene and/or activating the p38 pro-apoptotic gene |
WO2006031210A1 (en) * | 2003-05-29 | 2006-03-23 | Board Of Regents, The University Of Texas Systems | Jabi as a prognostic marker and a therapeutic target for human cancer |
CA2579574A1 (en) | 2004-07-23 | 2007-01-04 | The University Of North Carolina At Chapel Hill | Methods and materials for determining pain sensitivity and predicting and treating related disorders |
CN105106186A (zh) | 2008-01-31 | 2015-12-02 | 范德比尔特大学 | 治疗冠状动脉和动脉的动脉瘤性蛛网膜下腔出血的方法和组合物 |
KR20100135729A (ko) * | 2008-01-31 | 2010-12-27 | 반더빌트유니버시티 | 폐의 용태에 따른 치료 방법 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4394448A (en) * | 1978-02-24 | 1983-07-19 | Szoka Jr Francis C | Method of inserting DNA into living cells |
CA2059129C (en) * | 1989-06-22 | 1996-07-02 | Sean M. Sullivan | Encapsulation process |
CA2115742A1 (en) * | 1991-08-20 | 1993-03-04 | Ronald G. Crystal | Adenovirus mediated transfer of genes to the gastrointestinal tract |
US5496731A (en) * | 1993-03-25 | 1996-03-05 | Xu; Hong-Ji | Broad-spectrum tumor suppressor genes, gene products and methods for tumor suppressor gene therapy |
-
1991
- 1991-12-04 ES ES92902782T patent/ES2093248T3/es not_active Expired - Lifetime
- 1991-12-04 EP EP92902782A patent/EP0560932B1/en not_active Expired - Lifetime
- 1991-12-04 WO PCT/US1991/009100 patent/WO1992010573A1/en active IP Right Grant
- 1991-12-04 US US08/070,410 patent/US5651964A/en not_active Expired - Fee Related
- 1991-12-04 CA CA002096723A patent/CA2096723C/en not_active Expired - Fee Related
- 1991-12-04 DE DE69121903T patent/DE69121903T2/de not_active Expired - Fee Related
- 1991-12-04 JP JP4502955A patent/JPH06504671A/ja not_active Withdrawn
- 1991-12-04 DK DK92902782.9T patent/DK0560932T3/da active
- 1991-12-04 AT AT92902782T patent/ATE142261T1/de not_active IP Right Cessation
- 1991-12-04 AU AU91469/91A patent/AU651650B2/en not_active Ceased
-
1996
- 1996-11-28 GR GR960403196T patent/GR3021805T3/el unknown
-
2001
- 2001-08-01 JP JP2001234289A patent/JP3323491B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP3323491B2 (ja) | 2002-09-09 |
GR3021805T3 (en) | 1997-02-28 |
AU651650B2 (en) | 1994-07-28 |
ES2093248T3 (es) | 1996-12-16 |
JP2002114707A (ja) | 2002-04-16 |
EP0560932B1 (en) | 1996-09-04 |
ATE142261T1 (de) | 1996-09-15 |
AU9146991A (en) | 1992-07-08 |
EP0560932A1 (en) | 1993-09-22 |
JPH06504671A (ja) | 1994-06-02 |
CA2096723C (en) | 2006-03-28 |
DE69121903T2 (de) | 1997-04-10 |
DE69121903D1 (de) | 1996-10-10 |
CA2096723A1 (en) | 1992-06-05 |
US5651964A (en) | 1997-07-29 |
WO1992010573A1 (en) | 1992-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0560932T3 (ja) | ||
EP1064952A3 (en) | Methods and compositions for the suppression of neu mediated transformations | |
Christl et al. | Antagonistic effects of sulfide and butyrate on proliferation of colonic mucosa: a potential role for these agents in the pathogenesis of ulcerative colitis | |
Scheppach et al. | Role of short-chain fatty acids in the prevention of colorectal cancer | |
Paterson et al. | Molecular changes in oral cancer may reflect aetiology and ethnic origin | |
Nishihira et al. | Molecular and cellular features of esophageal cancer cells | |
Russo et al. | Development pattern of human breast and susceptibility to carcinogenesis | |
Thalmann et al. | Human prostate fibroblasts induce growth and confer castration resistance and metastatic potential in LNCaP Cells | |
Tatematsu et al. | Independent induction of intestinal metaplasia and gastric cancer in rats treated with N-methyl-N′-nitro-N-nitrosoguanidine | |
PL354334A1 (en) | Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes | |
PL353246A1 (en) | Compositions for the treatment and diagnosis of breast cancer and methods for their use | |
AU1807401A (en) | Compositions and methods for therapy and diagnosis of breast cancer | |
EP1007535A4 (en) | METHOD AND PREPARATIONS FOR DIAGNOSTIC AND TREATMENT OF BREAST CANCER | |
EP0672178A4 (en) | CELL GROWTH MODULATION WITH OLIGONUCLEOTIDS. | |
Leary, WP,* Robinson, KM,* Booyens, J.** & Dippenaar | Some effects of gamma-linolenic acid on cultured human oesophageal carcinoma cells | |
ZA982968B (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
DK0651636T3 (da) | Kemoterapi for cancer | |
Timmons et al. | Expression of galectin-7 during epithelial development coincides with the onset of stratification | |
Velcich et al. | Altered phenotype of HT29 colonic adenocarcinoma cells following expression of the DCC gene | |
Castle et al. | High level thrombospondin 1 expression in two NIH 3T3 cloned lines confers serum-and anchorage-independent growth. | |
Shamloo et al. | Dysregulation of adenosine kinase isoforms in breast cancer | |
JPH0784481B1 (ja) | ||
Wang et al. | The in vitro effect of vitamin D3 analogue EB‐1089 on a human prostate cancer cell line (PC‐3) | |
Thijssen et al. | Local aromatase activity in human breast tissues | |
PL350863A1 (en) | Compositions and methods for the treatment and diagnosis of breast cancer |